A blade of grass in a beating heart: Rice students find design needs bedside
Bioengineering students address 5 unmet health care needs through clinical immersion in Houston hospitals
Digital Health Institute welcomes French delegation to explore pathways to collaboration
The Houston Methodist-Rice Digital Health Institute recently welcomed Frank Marchetti, Consul General of France in Houston, and his team to discuss health care innovation and avenues for international collaboration.
New CPRIT awards expand Rice cancer research efforts
New funding from CPRIT will help Rice advance cancer research on several fronts, from strengthening a core genetic engineering facility that serves researchers across Texas to supporting new studies in cancer immunotherapy, next-generation radiation therapy and ovarian cancer.
First-in-human trial demonstrates promise of implantable cytokine factories for ovarian cancer
Rice researchers and collaborators at MD Anderson report results from a first-in-human trial evaluating a novel cell-based therapeutic platform in patients with advanced ovarian cancer.
An internal seed funding initiative will support 12 projects exploring brain health research.
Rice senior finds common ground between philosophy, medicine
“My journey has definitely been an exercise in broadening my academic interests every year,” said Annesha Dey.
Rice highlights ‘transformative’ cancer innovation, venture pipeline during CPRIT visit
Rice foregrounded its cancer research portfolio during a visit from Cancer Prevention and Research Institute of Texas senior officials.
From climate storytelling to AI innovation: Rice researchers take on global challenges at SXSW
At this year’s South by Southwest (SXSW) conference in Austin, Rice researchers explored how to close that gap, whether by rethinking how climate change is communicated or by accelerating scientific discovery through artificial intelligence.
CRISPR-based technique unlocks healing power of mitochondria for heart failure therapy
Rice researchers and collaborators induced heart cells to increase mitochondria production to optimal levels, opening a path toward a new therapy for heart failure.
A team of researchers led by Rice bioengineer Omid Veiseh has been awarded up to $18.2 million in funding from the Advanced Research Projects Agency for Health to develop a first-of-its-kind regenerative treatment aimed at restoring damaged lymphatic vessels and potentially curing lymphedema, a condition that affects more than 10 million Americans.
Texas Life Science Forum showcases medtech, biotech and health care innovation
More than 600 investors, entrepreneurs and industry leaders gathered at Rice Business Nov. 11 for the 14th annual Texas Life Science Forum, co-hosted by BioHouston and the Rice Alliance for Technology and Entrepreneurship. The event highlighted Houston’s growing leadership in life science innovation, commercialization and venture investment.
Rice’s Baker Institute appoints Russell as senior fellow and director of Center for Health Policy
Rice’s Baker Institute for Public Policy has named Dr. Heidi Russell as the director of the Center for Health Policy. She is also appointed as the L.E. and Virginia Simmons Senior Fellow in Health Policy and the Huffington Fellow in Child Health Policy. She will step into these roles at the Baker Institute Oct. 13.
New UTHealth Houston school highlighted at joint Rice-UTHealth workshop on AI and behavioral health
The Future of AI and Behavioral Health Workshop, a joint effort of Rice and UTHealth Houston, explored the intersection of artificial intelligence and behavioral health and served to spotlight the launch of UTHealth Houston’s new School of Behavioral Health Sciences.
Q&A: How Rice and Houston Methodist are building the future of digital health
Ahead of the Houston Methodist-Rice University Digital Health Institute Summit Oct.8, Rice News spoke with institute leadership about the institute’s vision, its distinctive assets and the opportunities it opens for the future of health care.
Biotechnology Innovation Organization president and CEO John F. Crowley visited Rice as part of a tour highlighting regional biotech hubs across the country.